-
1
-
-
77951088427
-
-
WHO, (accessed Feb 15, 2012).
-
Global tuberculosis control 2011 WHO, (accessed Feb 15, 2012). http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf.
-
Global tuberculosis control 2011
-
-
-
2
-
-
84861345560
-
Cost and cost-effectiveness of MDR-TB treatment in Estonia and Russian Federation
-
(in press).
-
Floyd K, Hutubessy R, Kliiman K, et al. Cost and cost-effectiveness of MDR-TB treatment in Estonia and Russian Federation. Eur Respir J (in press).
-
Eur Respir J
-
-
Floyd, K.1
Hutubessy, R.2
Kliiman, K.3
-
3
-
-
80053067126
-
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
-
Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011, 38:516-528.
-
(2011)
Eur Respir J
, vol.38
, pp. 516-528
-
-
Falzon, D.1
Jaramillo, E.2
Schünemann, H.J.3
-
4
-
-
77956497725
-
Rapid molecular detection of tuberculosis and rifampin resistance
-
Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015.
-
(2010)
N Engl J Med
, vol.363
, pp. 1005-1015
-
-
Boehme, C.C.1
Nabeta, P.2
Hillemann, D.3
-
5
-
-
84857646229
-
The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?
-
published online Oct 26.
-
Dheda K, Migliori GB The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?. Lancet 2011, published online Oct 26. 10.1016/S0140-6736(11)61062-3.
-
(2011)
Lancet
-
-
Dheda, K.1
Migliori, G.B.2
-
6
-
-
77955872446
-
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
-
Caminero JA, Sotgiu G, Zumla A, et al. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis 2010, 10:621-629.
-
(2010)
Lancet Infect Dis
, vol.10
, pp. 621-629
-
-
Caminero, J.A.1
Sotgiu, G.2
Zumla, A.3
-
8
-
-
84864745953
-
Childhood tuberculosis: progress requires advocacy strategy now
-
(in press).
-
Sandgren A, Cuevas LE, Dara M, et al. Childhood tuberculosis: progress requires advocacy strategy now. Eur Respir J (in press).
-
Eur Respir J
-
-
Sandgren, A.1
Cuevas, L.E.2
Dara, M.3
-
9
-
-
80053061470
-
Towards the development of EU/EEA standards for tuberculosis care (ESTC)
-
Migliori GB, Sotgiu G, Blasi F, et al. Towards the development of EU/EEA standards for tuberculosis care (ESTC). Eur Respir J 2011, 38:493-495.
-
(2011)
Eur Respir J
, vol.38
, pp. 493-495
-
-
Migliori, G.B.1
Sotgiu, G.2
Blasi, F.3
-
10
-
-
78549266205
-
Tuberculosis among children in Oslo, Norway, from 1998 to 2009
-
Krogh K, Surén P, Mengshoel AT, Brandtzæg P Tuberculosis among children in Oslo, Norway, from 1998 to 2009. Scand J Infect Dis 2010, 42:866-872.
-
(2010)
Scand J Infect Dis
, vol.42
, pp. 866-872
-
-
Krogh, K.1
Surén, P.2
Mengshoel, A.T.3
Brandtzæg, P.4
-
11
-
-
84861341121
-
Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis
-
published online Feb 27.
-
Ettehad D, Schaaf HS, Seddon J, Cooke GS, Ford N Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012, published online Feb 27. 10.1016/S1473-3099(12)70033-6.
-
(2012)
Lancet Infect Dis
-
-
Ettehad, D.1
Schaaf, H.S.2
Seddon, J.3
Cooke, G.S.4
Ford, N.5
|